Bristol-Myers Squibb Named to 2016 Dow Jones Sustainability Index North America
NEW YORK, September 13, 2016 /3BL Media/ Bristol-Myers Squibb Company (NYSE:BMY) has earned a place on the prestigious Dow Jones Sustainability Index (DJSI) North America for the second consecutive year. The index recognizes public companies for outstanding performance across economic, environmental and social factors, and serves as a benchmark for investors who integrate sustainability considerations into their portfolios.
Bristol-Myers Squibb is one of eight pharmaceutical, biotechnology and life sciences companies included on the 2016 North America Index.
“We are proud to receive this important recognition,” says Carol Powell, global head and vice president of Environment, Health, Safety and Sustainability. “Our commitment to corporate social responsibility is part of our culture and is embedded in the work we do on behalf of patients fighting serous disease. Our ambitious Sustainability Goals help us strengthen our fundamental business and support our position as a sustainability leader.”
The Bristol-Myers Squibb Sustainability 2020 Goals are aligned with the company mission and provide a platform to take the company’s commitment to economic growth, social responsibility and a healthy environment to the next level, and to do so with integrity and transparency. The final report on the Sustainability 2015 Goals is available at: http://www.bms.com/sustainability.
About the Dow Jones Sustainability Indices (DJSI)
This global ranking is published annually by the S&P Dow Jones Indices and RobecoSAM and measures the performance of the world’s sustainability leaders. RobecoSAM, a company focused exclusively on sustainability investing, invited 3,450 of the world’s largest publicly traded companies to participate in its 2016 Corporate Sustainability Assessment. RobecoSAM collects information about economic, environmental and social challenges and trends that are financially relevant to companies within a particular industry. The assessment focuses on sustainability factors that can have an impact on companies’ long-term value creation potential, and identifies companies that are more likely to outperform as a result of their adoption of sustainability best practices.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
For more information contact Lisa McCormick Lavery, 609-252-7602, firstname.lastname@example.org